Cytotoxicity assays revealed superior dose-dependent antiproliferative effects of OXY-CDNS against PC-3 (prostate cancer), HT-29, and HCT-116 (colon cancer) compared to free OXY, with minimal toxicity from blank NSs. Here, GCG is linked to malignant colon neoplasm.